Drug-like Annotation and Duplicate Analysis of a 23-Supplier Chemical Database Totalling 2.7 Million Compounds

Nicolas Baurin(Granta Design (United Kingdom)), Ruth L. Baker(Granta Design (United Kingdom)), C. E. Richardson(Granta Design (United Kingdom)), I‐Jen Chen(Granta Design (United Kingdom)), Nicolas Foloppe(Granta Design (United Kingdom)), Andrew Potter(Granta Design (United Kingdom)), Allan M. Jordan(Granta Design (United Kingdom)), Stephen D. Roughley(Granta Design (United Kingdom)), Martin J. Parratt(Granta Design (United Kingdom)), P. Alex Greaney(Granta Design (United Kingdom)), Dave Morley(Granta Design (United Kingdom)), Roderick E. Hubbard(Granta Design (United Kingdom))
Journal of Chemical Information and Computer Sciences
February 10, 2004
Cited by 115

Abstract

We have implemented five drug-like filters, based on 1D and 2D molecular descriptors, and applied them to characterize the drug-like properties of commercially available chemical compounds. In addition to previously published filters (Lipinski and Veber), we implemented a filter for medicinal chemistry tractability based on lists of chemical features drawn up by a panel of medicinal chemists. A filter based on the modeling of aqueous solubility (>1 microM) was derived in-house, as well as another based on the modeling of Caco-2 passive membrane permeability (>10 nm/s). A library of 2.7 million compounds was collated from the 23 compound suppliers and analyzed with these filters, highlighting a tendency toward highly lipophilic compounds. The library contains 1.6 M unique structures, of which 37% (607,223) passed all five drug-like filters. None of the 23 suppliers provides all the members of the drug-like subset, emphasizing the benefit of considering compounds from various compound suppliers as a source of diversity for drug discovery.


Related Papers

No related papers found

Powered by citation graph analysis